EUVIMEDEUVIMED entdecken
Crossref

Treatment Sequencing With Biologic Switching, Staged Excision, and Split‐Thickness Skin Grafting for Extensive Hidradenitis Suppurativa

Shunki Hashizumi, Ko Kagoyama iD, Hiroaki Ishida, Teruhiko Makino iD, Tadamichi Shimizu iD

The Journal of Dermatology · 14.10.2026

DOI: 10.1111/1346-8138.70538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 14.10.2026. Verfasst von Shunki Hashizumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of extensive multiregional hidradenitis suppurativa requires sequencing biologic therapy and surgery when active inflammation and irreversible structural disease coexist. A 58‐year‐old Japanese man with Hurley Stage III disease had inadequate overall control with adalimumab. At the assessment before medial‐thigh surgery, the International Hidradenitis Suppurativa Severity Score System score was 48. Because he sought prompt relief from painful drainage and daily wound care, bilateral scarred and tunnel‐bearing lesions were excised and reconstructed by staged split‐thickness skin grafting while adalimumab was continued. Local control was achieved, but disease persisted elsewhere, prompting a switch to bimekizumab. Inflammatory lesion counts decreased, but Hidradenitis Suppurativa Clinical Response was not achieved at week 16 and extensive gluteal scars and draining tunnels remained. Bilateral gluteal excision and staged grafting were therefore performed during continued bimekizumab treatment, without postoperative infection, bleeding, or graft failure. Six months after reconstruction, the severity score was 9 and the clinical response criterion was met, reflecting both decreased inflammatory activity during bimekizumab treatment and surgical removal of structural lesions. Gluteal local control persisted through 15 months. This case illustrates sequencing biologic switching and regional surgery according to inflammatory activity, persistent structural disease, and the need for prompt symptom relief.

Schlagwörter

Stichwörter der Autor:innen

adalimumabbimekizumabhidradenitis suppurativaoperative surgical proceduresskin transplantation

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.

ORCID-Profile: Ko Kagoyama, Teruhiko Makino, Tadamichi Shimizu

Zitieren

APA

Hashizumi, S., Kagoyama, K., Ishida, H., Makino, T., & Shimizu, T. (2026). Treatment Sequencing With Biologic Switching, Staged Excision, and Split‐Thickness Skin Grafting for Extensive Hidradenitis Suppurativa. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70538

Vancouver

Hashizumi S, Kagoyama K, Ishida H, Makino T, Shimizu T. Treatment Sequencing With Biologic Switching, Staged Excision, and Split‐Thickness Skin Grafting for Extensive Hidradenitis Suppurativa. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70538

BibTeX
@article{Hashizumi2026,
  author = {Hashizumi, Shunki and Kagoyama, Ko and Ishida, Hiroaki and Makino, Teruhiko and Shimizu, Tadamichi},
  title = {Treatment Sequencing With Biologic Switching, Staged Excision, and Split‐Thickness Skin Grafting for Extensive Hidradenitis Suppurativa},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70538}
}
Kostenlos starten →